![Orgad Laub](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Orgad Laub
Directeur Général chez Sealantium Medical Ltd.
Postes actifs de Orgad Laub
Sociétés | Poste | Début | Fin |
---|---|---|---|
Rimonyx Pharmaceuticals Ltd.
![]() Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel | Directeur/Membre du Conseil | - | - |
Sealantium Medical Ltd.
![]() Sealantium Medical Ltd. Medical SpecialtiesHealth Technology Sealantium Medical Ltd. develops a biodegradable bandage for the control of hemorrhage (bleeding), used in first aid, field trauma care, and surgery. The company was founded by Orgad Laub in 2011 and is headquartered in Netanya, Israel. | Directeur Général | 01/01/2011 | - |
Fondateur | 01/01/2011 | - |
Historique de carrière de Orgad Laub
Anciens postes connus de Orgad Laub
Sociétés | Poste | Début | Fin |
---|---|---|---|
Serono Corp. | Directeur/Membre du Conseil | - | - |
Weizmann Institute of Science | Corporate Officer/Principal | - | - |
Statistiques
Internationale
Israël | 5 |
Opérationnelle
Director/Board Member | 2 |
Corporate Officer/Principal | 1 |
Chief Executive Officer | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
Rimonyx Pharmaceuticals Ltd.
![]() Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel | Health Technology |
Serono Corp. | |
Sealantium Medical Ltd.
![]() Sealantium Medical Ltd. Medical SpecialtiesHealth Technology Sealantium Medical Ltd. develops a biodegradable bandage for the control of hemorrhage (bleeding), used in first aid, field trauma care, and surgery. The company was founded by Orgad Laub in 2011 and is headquartered in Netanya, Israel. | Health Technology |
- Bourse
- Insiders
- Orgad Laub
- Expérience